Maximum Dose of Ramipril
The maximum recommended dose of ramipril is 10 mg twice daily (20 mg total daily dose) for heart failure post-myocardial infarction, and 20 mg daily for hypertension. 1, 2
Dosing by Indication
Hypertension
- Maximum dose: 20 mg per day (administered as a single dose or in two equally divided doses) 2
- Starting dose: 2.5 mg once daily 2
- Usual maintenance range: 2.5-20 mg daily 2
- If antihypertensive effect diminishes toward the end of the dosing interval with once-daily dosing, consider increasing the dose or switching to twice-daily administration 2
Heart Failure Post-Myocardial Infarction
- Target maximum dose: 5 mg twice daily (10 mg total daily dose) 1, 2
- Starting dose: 2.5 mg twice daily (or 1.25 mg twice daily if hypotensive) 1, 2
- Titrate upward over approximately 3-week intervals after tolerating the starting dose for one week 2
- This target dose of 5 mg twice daily was used in the AIRE trial and demonstrated mortality benefit 1
Chronic Heart Failure (European Guidelines)
- Maintenance dose range: 2.5-5 mg twice daily 1
- Starting dose: 1.25-2.5 mg daily 1
- The European Society of Cardiology guidelines recommend titrating to 5 mg twice daily as the target maintenance dose 1
Dose Adjustments for Special Populations
Renal Impairment
- Creatinine clearance >40 mL/min: Use usual dosing regimens 2
- Creatinine clearance ≤40 mL/min: 2
- In severe renal impairment, 25% of the usual dose produces full therapeutic levels of the active metabolite ramiprilat 2
Volume Depletion or Renal Artery Stenosis
- Start at 1.25 mg once daily regardless of indication 2
- Titrate according to blood pressure response 2
Clinical Context
The maximum doses are based on evidence from major clinical trials demonstrating mortality and morbidity benefits. The AIRE trial used ramipril 5 mg twice daily in post-MI patients with heart failure and showed significant survival benefit 1. For hypertension, doses up to 20 mg daily have been studied and shown to be effective and well-tolerated 3, 4, 5, 6.
Important monitoring: After initial dosing, observe patients for at least 2 hours and until blood pressure stabilizes for an additional hour 2. Check serum potassium and creatinine after 5-7 days of initiation or dose changes 1.